ElmediX NV – Trademark Portfolio

Entity Type: 99

ElmediX NV holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ELMEDIX, TEMPOCURE, and TEMPOSENSOR. The owner is based in Leuven.

Esperantolaan 4

Leuven B-3001 , BE

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ElmediX NV's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ElmediX NV have?

ElmediX NV has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does ElmediX NV file in?

ElmediX NV files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ElmediX NV's most well-known trademarks?

ElmediX NV's registered trademark portfolio includes well-known marks such as ELMEDIX, TEMPOCURE, and TEMPOSENSOR. These are among 3 currently registered trademarks in the portfolio.

What is ElmediX NV's trademark registration success rate?

ElmediX NV has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.